IFRX
InflaRx N.V.
Key Financials
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13G | 8/17/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| 424B5 | 8/14/2026 | View on SEC |
| SCHEDULE 13G | 8/14/2026 | View on SEC |
| SCHEDULE 13G/A | 8/14/2026 | View on SEC |
| EFFECT | 8/12/2026 | View on SEC |
| SCHEDULE 13G | 8/6/2026 | View on SEC |
| F-3 | 8/6/2026 | View on SEC |
| S-8 | 8/6/2026 | View on SEC |
| 6-K | 8/6/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | IFRX |
| Company Name | InflaRx N.V. |
| CIK | 1708688 |
| Sector | Pharmaceutical Preparations |
| Industry | Non-accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | other |
| Fiscal Year End | 1231 |
| State of Incorporation | P7 |
| Phone | 49 3641 508180 |